PRAX — Praxis Precision Medicines Share News
0.000.00%
Last trade - 00:00Praxis Precision Medicines rises as epilepsy drug cuts seizures in children
Brief: Praxis Precision Medicines Announces Positive Results From The Embrave Part A Trial Of Elsunersen In Patients With Scn2a Early-Onset Developmental And Epileptic Encephalopathy
Brief: Praxis Precision Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Dropbox, Etsy, Zscaler
Praxis Precision posts bigger Q4 loss as R&D costs grow
Brief: Praxis Precision Q4 EPS USD -3.5
Brief: Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule
Brief: Praxis Precision Medicines Inc - Two NDA Submissions Expected By Mid-Feb 2026 For Ulixacaltamide In Essential Tremor & Relutrigine In Scn2a/8A-Dees
U.S. STOCKS ON THE MOVE-Nvidia, Boeing, Lowe's
U.S. STOCKS ON THE MOVE-Netflix, Alumis, Micron Technology
U.S. STOCKS ON THE MOVE-Hershey, Praxis Precision, Cal-Maine Foods
Praxis Precision Medicines edges down after $575 mln stock sale
Brief: Praxis Precision Medicines Prices Public Offering Of 2.2 Mln Shares At $260 Per Share
Praxis Precision Medicines slips after announcing equity offering plans
Brief: Praxis Precision Medicines, Inc. Announces Proposed Public Offering
Praxis Precision climbs after FDA's 'breakthrough' tag for tremor drug
Praxis Precision climbs after FDA's 'breakthrough' tag for tremor drug
U.S. RESEARCH ROUNDUP-Expedia Group, Hasbro, Palisade Bio
Brief: Praxis Precision Medicines Announces Alignment With FDA